These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21782798)

  • 1. Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.
    Yang MH; Chu PY; Chen SC; Chung TW; Chen WC; Tan LB; Kan WC; Wang HY; Su SB; Tyan YC
    Biochem Biophys Res Commun; 2011 Aug; 411(4):714-20. PubMed ID: 21782798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
    Tyan YC; Yang MH; Chen SC; Jong SB; Chen WC; Yang YH; Chung TW; Liao PC
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2851-62. PubMed ID: 21913264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for the tumor-related proteins of transition cell carcinoma in Taiwan by proteomic analysis.
    Sheng KH; Yao YC; Chuang SS; Wu H; Wu TF
    Proteomics; 2006 Feb; 6(3):1058-65. PubMed ID: 16400682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
    Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
    J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling of ADAM12 in human bladder cancer.
    Fröhlich C; Albrechtsen R; Dyrskjøt L; Rudkjaer L; Ørntoft TF; Wewer UM
    Clin Cancer Res; 2006 Dec; 12(24):7359-68. PubMed ID: 17189408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
    Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of cell cycle biomarkers in nonmuscle invasive bladder transitional cell carcinoma.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    J Urol; 2007 Feb; 177(2):481-7; discussion 487. PubMed ID: 17222615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
    Chen CL; Lai YF; Tang P; Chien KY; Yu JS; Tsai CH; Chen HW; Wu CC; Chung T; Hsu CW; Chen CD; Chang YS; Chang PL; Chen YT
    J Proteome Res; 2012 Dec; 11(12):5611-29. PubMed ID: 23082778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
    Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
    Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
    Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
    Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential detection of S100A8 in transitional cell carcinoma of the bladder by pair wise tissue proteomic and immunohistochemical analysis.
    Tolson JP; Flad T; Gnau V; Dihazi H; Hennenlotter J; Beck A; Mueller GA; Kuczyk M; Mueller CA
    Proteomics; 2006 Jan; 6(2):697-708. PubMed ID: 16252305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary levels of soluble e-cadherin in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Matsumoto K; Casella R; Jian W; Lerner SP
    Eur Urol; 2005 Jul; 48(1):69-76. PubMed ID: 15967254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
    Tong GX; Yee H; Chiriboga L; Hernandez O; Waisman J
    Hum Pathol; 2005 Jul; 36(7):741-6. PubMed ID: 16084942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder.
    Sánchez-Carbayo M; Herrero E; Megias J; Mira A; Espasa A; Chinchilla V; Soria F
    J Urol; 1999 Apr; 161(4):1110-5. PubMed ID: 10081849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC; Nutt JE; Rajjayabun PH; Neal DE; Lunec J; Mellon JK
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine.
    Celis JE; Rasmussen HH; Vorum H; Madsen P; Honoré B; Wolf H; Orntoft TF
    J Urol; 1996 Jun; 155(6):2105-12. PubMed ID: 8618345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching cell-secreted proteomes for potential urinary bladder tumor markers.
    Lin CY; Tsui KH; Yu CC; Yeh CW; Chang PL; Yung BY
    Proteomics; 2006 Aug; 6(15):4381-9. PubMed ID: 16819731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
    Svatek RS; Herman MP; Lotan Y; Casella R; Hsieh JT; Sagalowsky AI; Shariat SF
    Cancer; 2006 Apr; 106(8):1701-7. PubMed ID: 16541433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.